Due to the ease of administration and high level of satisfaction, we’re excited to see the rise of dermal fillers continuing in the cosmetics industry. At Fox Pharma, we’re proud to say that the Hyaluronic Acid (HA) in our signature products such as REVOLAX is crosslinked with no BDDE residue detected, but what does that really mean? Let us break it down for you to make things a little easier.
What is hyaluronic acid?
Hyaluronic Acid is a naturally occurring substance that is found throughout the body’s cells. Clusters are found most densely in the skin but also occur in cartilage, connective tissue and fluid that lubricates the joints. As a highly soluble substance, Hyaluronic Acid can hold up to 1000 times its weight in H20 molecules. Due to the excellent absorption properties of the molecules, this makes it an excellent candidate for volumising and plumping skin.
Why is cross-linking important in dermal fillers?
In its natural state, HA is enzymatic and breaks down at rapid speeds. Therefore, in order to sustain turnover of the molecules, they must be chemically engineered to create a thicker gel in comparison to the usual liquid form.
By transforming the liquid into a gel, polymer chains are crosslinked together to maintain shape for a longer period of time and slow the process of disintegrating. The more links that are created, the thicker the product becomes and more difficult it is for the body to breakdown and disintegrate. This can extend the longevity of dermal fillers.
We are proud to have formulated The Nation’s Favourite Dermal Filler, REVOLAX. REVOLAX ingredients have a unique cross-linking structure which maintains a low percentage of product migration. This means that the product is able to stay close to the injection site. As REVOLAX is highly cross-linked, results are long-lasting when compared to other dermal fillers, as the skin takes longer to break down the filler. Register with us to discover and shop the full REVOLAX range at Fox Pharma, for results that will exceed your clients’ expectations.